Correlation Between Pfizer and Methanex

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Pfizer and Methanex at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Pfizer and Methanex into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Pfizer Inc CDR and Methanex, you can compare the effects of market volatilities on Pfizer and Methanex and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Pfizer with a short position of Methanex. Check out your portfolio center. Please also check ongoing floating volatility patterns of Pfizer and Methanex.

Diversification Opportunities for Pfizer and Methanex

-0.51
  Correlation Coefficient

Excellent diversification

The 3 months correlation between Pfizer and Methanex is -0.51. Overlapping area represents the amount of risk that can be diversified away by holding Pfizer Inc CDR and Methanex in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Methanex and Pfizer is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Pfizer Inc CDR are associated (or correlated) with Methanex. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Methanex has no effect on the direction of Pfizer i.e., Pfizer and Methanex go up and down completely randomly.

Pair Corralation between Pfizer and Methanex

Assuming the 90 days trading horizon Pfizer Inc CDR is expected to under-perform the Methanex. But the stock apears to be less risky and, when comparing its historical volatility, Pfizer Inc CDR is 1.45 times less risky than Methanex. The stock trades about -0.07 of its potential returns per unit of risk. The Methanex is currently generating about 0.03 of returns per unit of risk over similar time horizon. If you would invest  5,017  in Methanex on August 27, 2024 and sell it today you would earn a total of  1,409  from holding Methanex or generate 28.08% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthVery Weak
Accuracy100.0%
ValuesDaily Returns

Pfizer Inc CDR  vs.  Methanex

 Performance 
       Timeline  
Pfizer Inc CDR 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Pfizer Inc CDR has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of latest unfluctuating performance, the Stock's basic indicators remain healthy and the recent disarray on Wall Street may also be a sign of long period gains for the firm investors.
Methanex 

Risk-Adjusted Performance

2 of 100

 
Weak
 
Strong
Weak
Compared to the overall equity markets, risk-adjusted returns on investments in Methanex are ranked lower than 2 (%) of all global equities and portfolios over the last 90 days. In spite of very healthy basic indicators, Methanex is not utilizing all of its potentials. The recent stock price disarray, may contribute to short-term losses for the investors.

Pfizer and Methanex Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Pfizer and Methanex

The main advantage of trading using opposite Pfizer and Methanex positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Pfizer position performs unexpectedly, Methanex can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Methanex will offset losses from the drop in Methanex's long position.
The idea behind Pfizer Inc CDR and Methanex pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Comparator module to compare the composition, asset allocations and performance of any two portfolios in your account.

Other Complementary Tools

Pair Correlation
Compare performance and examine fundamental relationship between any two equity instruments
Money Managers
Screen money managers from public funds and ETFs managed around the world
AI Portfolio Architect
Use AI to generate optimal portfolios and find profitable investment opportunities
Equity Valuation
Check real value of public entities based on technical and fundamental data
Efficient Frontier
Plot and analyze your portfolio and positions against risk-return landscape of the market.